Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-1986 | 10-1985 | 10-1984 | |
| Gross Profit | 16,490 | 12,563 | 5,207 |
| Operating Expenses | 909 | 661 | 290 |
| Operating Income | -909 | -661 | -290 |
| Pre-tax Income | -909 | -661 | -290 |
| Net Income Continuous | -909 | -661 | -290 |
| Net Income | $-909 | $-661 | $-290 |
| EBITDA(a) | $-33 | $84 | $11 |